AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)

306 reported adverse events

Drug classes: Endoglycosidase [EPC]

These side effects are most commonly reported by patients taking AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT):

# Side effect Count
0 RASH 47
1 INFUSION RELATED REACTION 32
2 PARONYCHIA 29
3 OFF LABEL USE 22
4 NAUSEA 17
5 STOMATITIS 17
6 PYREXIA 14
7 ADMINISTRATION RELATED REACTION 13
8 DECREASED APPETITE 13
9 PRURITUS 12
See all common reactions for AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)

AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION RELATED REACTION 13 0.0667
1 LARYNGEAL WEB 1 0.0667
2 OCULAR SURFACE SQUAMOUS NEOPLASIA 1 0.0400
3 PENILE DERMATITIS 1 0.0159
4 NAIL DEFORMATION 1 0.0149
5 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
6 PARONYCHIA 29 0.0066
7 SCABIES 1 0.0058
8 PENILE BLISTER 1 0.0047
9 KL-6 INCREASED 1 0.0044
See all enriched reactions for AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)